New fat-loss pills work ‘quicker than Ozempic and have similar fat-melting results’

A NEW pill could have the same felt melting result as Ozempic jab, a study reveals.

Danuglipron, created by Pfizer, was tested on 411 adults with Type 2 diabetes.

PAPfizer’s pill could have the same felt melting result as the Ozempic jab, a study reveals.[/caption]

Patients who took 120-milligram lost around or 4.6 kilograms (kgs) over a 16 week period, the study published in JAMA Network found .

For comparison, in Ozempic’s phase three trial, patients who received up to two-milligram injections of the drug once a week for 30 weeks 4.53kg.

As an oral treatment, the drug could be an easier for many people wanting the jab

The study results also suggest danuglipron could work quicker than Ozempic as people who took the pills lost nearly the same amount of weight as those who took the jab but in almost half the time.

However, it’s worth noting there were are stark differences in dosage levels. 

Ozempic is authorised in the UK to treat diabetes and was recently found being sold illegally online as a weight-loss drug.

Wegovy, is the same medication, but will be offered on prescription to obese adults as a specialist weight loss treatment.

The two drugs have been making headlines over the last two years, since being dished out privately to the rich and famous.

It’s rumoured to have been used by celebs like Kim Kardashian and Twitter boss Elon Musk.

Danuglipron, Ozempic and Wegovy all work by suppressing the appetite – mimicking a naturally occurring hormone called glucagon-like peptide-1, which is usually released after eating.

As a result patients feel fuller for longer, and reduce the number of calories they eat.

Alongside the side effects, some charities have warned the drugs could be dangerous for people at risk of developing disorders.

They have also been liked to potential side effects – including sickness, bloating, acid reflux, constipation and diarrhoea.

Studies show in rare cases the medicines can cause pancreatitis, kidney function issues, thyroid C-cell tumours and medullary thyroid carcinoma.

Most people will also regain any weight they’ve lost after they stop taking the medication, research shows.

  Read More 

Advertisements